Obesity exerts its effects on the endometrium via three processes primarily, i.e., increased insulin (secondary to insulin resistance), increased aromatase, and imbalanced adipokines (increased leptin, decreased adiponectin), pretty much as is the case with the breast 83, 84. The gene discussed is CYP19A1; the disease is obesity disorder.